This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE / September ...
HOUSTON, TX / ACCESSWIRE / September 18, 2024 / Mann Eye Institute, a leading provider of comprehensive eye care services in Texas, is proud to announce its 47th anniversary. Founded on October 31, ...
BioMed X, a German biomedical research institute, announced the start of a new research team at the BioMed X Institute in ...
FIRST COLLABORATIVE EFFORT UNDER NEW AGREEMENT ALLEN, TX / ACCESSWIRE / September 18, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Department of ...
The rebrand reinforces the company's commitment to simplifying healthcare administration and streamlining credentialing to help providers focus on patient care.AUSTIN, TX / ACCESSWIRE / September 18, ...
Partnership enables an integration to improve the productivity of clinical development team. SAN DIEGO, September 18, 2024 (Newswire.com) - Faro Health Inc., the leading AI-powered platform for ...
STONY BROOK, NY / ACCESSWIRE / September 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it ...
REDWOOD CITY, CA / ACCESSWIRE / September 18, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based ...
Allowed claims cover major features of pumping mechanism in FDA-cleared MODD1 productSAN DIEGO, CA / ACCESSWIRE / September 18, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the ...
As cancer rates continue to climb, the market for AI in cancer diagnostics is witnessing remarkable growth. This surge is driven not only by the increasing prevalence of the disease but also by a ...
GENEVA, SWITZERLAND / ACCESSWIRE / September 18, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback